Please enable Javascript to use all features and improve your user experience.
EHC 2024
Programme
Posters
Search
EN
Back
Poster session
PoS 4
ePoster 04
Appointment
Date:
06.12.
Time:
12:30
–
13:30
Location / Stream:
ePoster station 4
Programme
ePoster
P284
Intravenous dihydroergotamine for primary headache disorders: factors to consider for an optimal outcome – a service evaluation
Pubudu Amarasena (London, GB)
ePoster
P285
Rimegepant for the acute treatment of migraine – a phase 3, multicenter, open-label, long-term safety study in adults from China
Shengyuan Yu (Beijing, CN)
ePoster
P286
Moderate to vigorous intensity exercise for cluster headaches: insights from case summaries and literature review
Mi-kyoung Kang (Hwaseong, KR)
ePoster
P287
Intravenous valproic acid treatment in patients with chronic refractory migraine: our experience in pediatric age
Fabiana Ursitti (Roma, IT)
ePoster
P288
Acute medication overuse in people with migraine from the 2022 European National Health & wellness survey
Lucy Abraham (Tadworth, GB)
ePoster
P289
Influence of withdrawal from overused drug on central sensitization mechanisms in chronic migraine with medication overuse headache
Gabriele Sebastianelli (Latina, IT)
ePoster
P290
Iron deposition in periaqueductal gray matter for migraine and medication-overuse headache: an observational study based on quantitative susceptibility mapping
Kaiming Liu (Hang Zhou, CN)
ePoster
P291
Analysis of demographic and comorbid factors in age- and sex matched groups of patients with and without medication overuse headache
Elena Lebedeva (Yekaterinburg, RU)
ePoster
P292
Is the 15-day threshold in the definition of migraine worsening associated to medication overuse reasonable
Laura Zanandrea (Milano, IT)
ePoster
P293
The evaluation of childhood trauma, theory of mind, and Alexithymia in patients with migraine and medication overuse headache
Esra Aciman Demirel (Zonguldak, TR)
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy